Pulsed Electrostatic Fields (ETG) to Reduce Hair
Loss in Women Undergoing Chemotherapy for Breast Carcinoma: A Pilot Study
Benji Benjamin, Danute Ziginskas, John Harman and Timothy
Aims: To determine whether specific pulsed electrostatic
fields, or electrotrichogenesis (ETG), could potentially prevent or reduce
hair loss in patients undergoing adjuvant cyclophosphamide, methotrexate
and 5-fluorouracil (CMF) chemotherapy for breast cancer.
International Journal of Dermatology, 1992
Evidence of Efficacy and
Safety on Extended Use
W. Stuart Maddin, M.D., F.R.C.P., Ingrid Amara, Dr.P.H.,
William A. Sollecito, Dr.P.H.
These data represent a subset of
data from the original 36-week study conducted by Maddin et al.,
which was in itself a preliminary study of a pulsed
electrical stimulation device in male subjects alone.
American Journal of Electromedicine, 1992
Stanley H. Kornhauser, Ph.D. and W. Stuart Maddin, M.D.
A recent clinical trial, now being expanded into a multi-center study
covering both males and females, has demonstrated the effectiveness of
treatments with an electrostatic field in reversing androgenetic alopecia
(common baldness). W. Stuart Maddin, M.D., F.R.C.P.C., responds to
questions posed by Dr. Stanley Kornhauser regarding this new application.
International Journal of Dermatology, 1990
The Biological Effects of a Pulsed
Electrostatic Field with Specific Reference to Hair
W. Stuart Maddin, M.D., F.R.C.P.(C),
Peter W. Bell, B.Sc. (Pharm.),
and John H.M. James, M.D., C.C.F.P.C.
From the Division of Dermatology, University of British Columbia School
of Medicine, Vancouver, British Columbia, Canada
This comparative, controlled study demonstrates the positive biological
effect on hair regrowth of a pulsed electrical field administered
according to a regularized treatment schedule over 36 weeks.
For additional information on case
studies carried out in Canada.
To find out more about the people
behind the ETG Treatment.